Review Article

The Typical Presentation Spectrum of Deep Vein Thrombosis Associated with Inferior Vena Cava Malformations

Table 3

Hospital and long-term treatment of DVT and follow-up.

Hospital management n, (%)
 Unfractionated heparin54(35.2%)
 LMWH34(22.1%)
 Prosthetic bypass18(11.7%)
 PCDT13(8.4%)
 Surgical thrombectomy3(1.9%)
 IVC-filter1(0.6%)
 Nonspecified anticoagulation31(20.1%)

Long-term treatment n, (%)
 Prolonged/lifelong VKA135(71.8%)
 Prolonged/lifelong VKA +32(17%)
 Compression stockings
 6-month VKA11(5.8%)
 12-month VKA8(4.4%)

Follow-up duration in months
 Mean ± SD12.85 ± 12.4
 Range1–60

DVT, deep vein thrombosis; IV, intravenous; LMWH, low molecular weight heparin; PCDT, pharmacomechanical catheter-directed thrombolysis; VKA, vitamin K antagonist; SD, standard deviation.
Out of 154, 34 cases are not reported.
Reported only in 60 cases.